No abstract available
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Angiostatins
-
Animals
-
Antineoplastic Agents / therapeutic use*
-
Carcinoma, Small Cell / drug therapy
-
Collagen / therapeutic use
-
Endostatins
-
Humans
-
Hydroxamic Acids / therapeutic use
-
Lung Neoplasms / drug therapy
-
Matrix Metalloproteinase Inhibitors*
-
Mice
-
Neoplasms / drug therapy*
-
Neoplasms, Experimental / drug therapy
-
Neovascularization, Pathologic / drug therapy*
-
Peptide Fragments / therapeutic use
-
Plasminogen / therapeutic use
-
Protease Inhibitors / therapeutic use*
-
Randomized Controlled Trials as Topic
Substances
-
Angiogenesis Inhibitors
-
Antineoplastic Agents
-
Endostatins
-
Hydroxamic Acids
-
Matrix Metalloproteinase Inhibitors
-
Peptide Fragments
-
Protease Inhibitors
-
Angiostatins
-
Plasminogen
-
Collagen
-
marimastat